Wake News

Wake Announces Transition in Leadership Team

Welcomes Mark M. McKenzie, M.D. as Medical Director

[Chattanooga, TN] – ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director.

“I have a passion for medical care and the difference it makes in the lives of individuals”, said Mark M. McKenzie, MD. “Clinical research is essential to that effort, and as an investigator, I am committed to carrying on the mission of ClinSearch as we partner with sponsors in providing reliable data in the development of new therapies.”

Dr. McKenzie assumed leadership at ClinSearch in 2017. Dr. Krause will remain with the organization as a consultant.

About Dr. Mark M. McKenzie

Dr. McKenzie is a physician who completed medical school and residency at the Medical College of Ohio / University of Toledo.  His undergraduate degrees are from Southern Adventist University.  He practiced internal medicine in the Chattanooga area for the last 15 years and has experience as a Sub-Investigator in nearly 100 clinical research studies.

About ClinSearch

ClinSearch built a research team recruited for their analytical skills as well as their genuine compassion and ability to relate to study volunteers. This group has performed admirably in community outreach events, educating and performing health screening assessments to a diversity of community groups. The staff works an expanded day to accommodate participant schedules and will often see patients on weekends or evenings to ensure success.

ClinSearch is a wholly-owned subsidiary of Wake Research Holdings, and an integral member of its integrated network of premier investigational sites.

About Wake Research

Wake Research is an integrated network of premier investigational sites, committed to excellence, working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device and pharmaceutical industries. Wake Research‘s 13 sites are fully equipped to meet the needs of sponsors and CROs in the conduct of Phase I-IV clinical trials in a large variety of indications.

Wake Research is known for effectively combining strategic volunteer recruitment and retention with high-quality clinical trial conduct, using standardized operating procedures and centralized marketing and advertising to ensure rapid subject enrollment. Wake Research has conducted over 6,000 research studies for hundreds of pharmaceutical and biotech sponsors and CROs since 1984. Wake Research’s mission is to bring novel medications, biologics and devices through clinical research to as many people as possible while providing unparalleled service and exceptional value to clinical trial partners and stakeholders.